$65.96
0.00 (0%)
Respironics, Inc. (NASDAQ:RESP.DL)
CAPS Rating:
The Company designs, develops, manufactures and markets medical devices used for the treatment of patients suffering from sleep and respiratory disorders.
RSS Headlines
Fool UK